121 related articles for article (PubMed ID: 22102464)
1. Botulinum toxin-induced focal paresis in mice is unaffected by muscle activity.
Kutschenko A; Reinert MC; Klinker F; Paulus W; Hesse S; Liebetanz D
Muscle Nerve; 2011 Dec; 44(6):930-6. PubMed ID: 22102464
[TBL] [Abstract][Full Text] [Related]
2. Accurate quantification of tetanus neurotoxin-induced focal spasticity in mice using complex running wheels.
Kutschenko A; Reinert MC; Klinker F; Paulus W; Hesse S; Liebetanz D
J Neurosci Methods; 2012 Mar; 205(1):45-8. PubMed ID: 22227534
[TBL] [Abstract][Full Text] [Related]
3. Treadmill running upregulates the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A injection.
Tsai SW; Tung YT; Chen HL; Shen CJ; Chuang CH; Tang TY; Chen CM
J Orthop Res; 2013 Jan; 31(1):125-31. PubMed ID: 22733692
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
Eleopra R; Montecucco C; Devigili G; Lettieri C; Rinaldo S; Verriello L; Pirazzini M; Caccin P; Rossetto O
Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
[TBL] [Abstract][Full Text] [Related]
5. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
6. BoNT/AB hybrid maintains similar duration of paresis as BoNT/A wild-type in murine running wheel assay.
Kutschenko A; Reinert MC; Krez N; Liebetanz D; Rummel A
Neurotoxicology; 2017 Mar; 59():1-8. PubMed ID: 28043867
[TBL] [Abstract][Full Text] [Related]
7. Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis.
Yen MT; Wall VK
Ann Plast Surg; 2008 Jan; 60(1):6-9. PubMed ID: 18281786
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins.
Torii Y; Goto Y; Takahashi M; Ishida S; Harakawa T; Sakamoto T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):407-14. PubMed ID: 19778548
[TBL] [Abstract][Full Text] [Related]
9. Histology and function of the internal anal sphincter after injection of botulinum toxin.
Langer JC; Birnbaum EE; Schmidt RE
J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
[TBL] [Abstract][Full Text] [Related]
10. Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection.
Manske SL; Boyd SK; Zernicke RF
Bone; 2010 Jan; 46(1):24-31. PubMed ID: 19853070
[TBL] [Abstract][Full Text] [Related]
11. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.
Hamjian JA; Walker FO
Muscle Nerve; 1994 Dec; 17(12):1385-92. PubMed ID: 7969239
[TBL] [Abstract][Full Text] [Related]
12. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.
Borodic GE; Ferrante R; Pearce LB; Smith K
Mov Disord; 1994 Jan; 9(1):31-9. PubMed ID: 8139603
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injections as a method for chemically denervating skeletal muscle to test functional hypotheses: a pilot study in Lepomis cyanellus.
O'Neill MW; Gibb AC
Physiol Biochem Zool; 2007; 80(2):241-9. PubMed ID: 17252520
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats.
Sakamoto T; Torii Y; Takahashi M; Ishida S; Goto Y; Nakano H; Harakawa T; Ginnaga A; Kozaki S; Kaji R
Toxicon; 2009 Nov; 54(6):857-61. PubMed ID: 19559720
[TBL] [Abstract][Full Text] [Related]
15. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
Torii Y; Takahashi M; Ishida S; Goto Y; Nakahira S; Harakawa T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):662-5. PubMed ID: 19781565
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of botulinum toxin on neuromuscular function.
Frick CG; Richtsfeld M; Sahani ND; Kaneki M; Blobner M; Martyn JA
Anesthesiology; 2007 Jun; 106(6):1139-46. PubMed ID: 17525589
[TBL] [Abstract][Full Text] [Related]
17. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
[TBL] [Abstract][Full Text] [Related]
19. Effects of botulinum toxin A on functional outcome during distraction osteogenesis.
Olabisi R; Best TM; Vanderby R; Petr S; Noonan KJ
J Orthop Res; 2007 May; 25(5):656-64. PubMed ID: 17262822
[TBL] [Abstract][Full Text] [Related]
20. Effects of botulinum toxin A injection and exercise on the growth of juvenile rat gastrocnemius muscle.
Chen CM; Stott NS; Smith HK
J Appl Physiol (1985); 2002 Oct; 93(4):1437-47. PubMed ID: 12235045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
